Episode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Episode 125 - Top Papers from the 2025 American Diabetes Association (ADA) Session
-
Narrated by:
-
By:
About this listen
Send us a text
Welcome back Rounds Table Listeners! We are back today with a special Rapid Fire Podcast. This week, Dr. Mike Fralick and guest host Danielle Cutler discuss the top papers from the 2025 American Diabetes Association (ADA) Scientific Session. Hot off the presses, here we go!
- Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial (0:00 - 6:05)
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes (6:06 - 13:22)
- Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (13:23 - 20:35)
The Good Stuff:
- Diabetes Trial Files - Free monthly newsletter! Subscribe at https://diabetestrialfiles.substack.com/ (20:36 - 21:00)
- Congrats to Danielle and all the med students finishing their academic year! (21:01 - 21:57)
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
No reviews yet